Restoration of CDKN2A into Melanoma Cells Induces Morphologic Changes and Reduction in Growth Rate but Not Anchorage-Independent Growth Reversal

This publication has 38 references indexed in Scilit:

• Involvement of the cyclin-dependent kinase inhibitor p16 (INK4a) in replicative senescence of normal human fibroblasts
  Proceedings of the National Academy of Sciences, 1996
• Infrequent Mutation of p16INK4 in Sporadic Melanoma
  Journal of Investigative Dermatology, 1996
• The current situation with regard to human melanoma and genetic inferences
  Current Opinion in Oncology, 1996
• Frequency of homozygous deletion at p16/CDKN2 in primary human tumours
  Nature Genetics, 1995
• Growth suppression by p18, a p16INK4/MTS1- and p14INK4B/MTS2-related CDK6 inhibitor, correlates with wild-type pRb function.
  Genes & Development, 1994
• pl5INK4B is a potentia| effector of TGF-β-induced cell cycle arrest
  Nature, 1994
• Cyclin D1 is a nuclear protein required for cell cycle progression in G1.
  Genes & Development, 1993
• Assignment of a Locus for Familial Melanoma, MLM, to Chromosome 9p13-p22
  Science, 1992
• Suppression of Tumorigenicity of Human Prostate Carcinoma Cells by Replacing a Mutated RB Gene
  Science, 1990
• Surface antigens of melanocytes and melanomas. Markers of melanocyte differentiation and melanoma subsets.
  The Journal of Experimental Medicine, 1982